NEW YORK, NY / ACCESS Newswire / November 20, 2025 / If you suffered a loss on your Avantor, Inc. (NYSE:AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=178327&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

(NasdaqGM:SLGL),(NASDAQ:VTRS), Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug's commercial potential In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY Sol-Gel signed an additional agreement with Viatris covering Australia and New Zealand for both EPSOLAY and TWYNEO

(NASDAQ:SGBX), The following is a letter to shareholders from the CEO of Safe & Green Holdings Corp. CONROE, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) — via IBN — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”) — As we approach one year since Olenox/NAHD assumed an active leadership role at

(NASDAQ:EDBL),(NASDAQ:EDBLW), Provides More Consumers in New York and New Jersey Access to the Company's Full Line of Organic Herbs and Sustainably Grown Produce Expands Edible Garden's Reach While Supporting Demand for Fresh, Clean-Label Foods BELVIDERE, NJ, Nov. 20, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a

(NASDAQ:PSTV),(NYSE:HUM), HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide(R)

SEOUL, South Korea, Nov. 20, 2025 (GLOBE NEWSWIRE) — MicrobiotiX, a company specializing in the development of novel bacteriophage therapeutics, announced on the 12th of November 2025 that it has signed a memorandum of understanding (MoU) with the West Africa Centre for Innovative Research and Care (WAFCIRC), working with Komfo Anokye Teaching Hospital (KATH) and

(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ), Collaboration uses Receptor AI's platform to design highly selective anti-cancer kinase inhibitor products for BriaPro, a BriaCell subsidiary Partnership expected to expand BriaPro's small-molecule pipeline Aims to accelerate the development of next generation therapeutics with improved efficacy and safety PHILADELPHIA and VANCOUVER, British Columbia and BOSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics

(NASDAQ:BIIB), New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the potential for additional long-term clinical benefits with continued treatment, and real-world experience Biogen is committed to deepening scientific understanding of Alzheimer's disease, including therapeutic delivery and disease progression CAMBRIDGE, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) — Biogen Inc.

(TSX:XTRA),(Frankfurt:0PL),(OTC US:XTRAF),(Other OTC:XTRAF), TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that it will release fiscal 2026 first quarter results after the

MONTREAL, Nov. 20, 2025 (GLOBE NEWSWIRE) — What: Families looking for an educational and fun weekend activity are invited to discover Shriners Hospitals for Children Canada during its Open House. Children can enjoy hands-on activities including magic and science shows, face painting, pet therapy sessions, and interactive learning stations. Parents will have the chance to